Daily Equity Reports 28 June 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 28 THJUNE 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 39592.08 INDIAN EQUITY BENCHMARK - Nifty ended on flat note on the last day of the June F&O series in the volatile session. At close, the Sensex was down 5.67 points at 39,586.41, while NIFTY 11847.55 Nifty was down 6 points at 11,841.50. About 1388 shares CLOSE PREVIOUS have advanced, 1121 shares declined, and 162 shares are NIKKEI 21086.59 unchanged. M&M, Tata Motors, Indiabulls Housing, Eicher Motors and Bharti Infratel were among major gainers on the 28221.98 Nifty, while losers were Tech Mahindra, HCL Tech, Hindalco, 2134.32 Reliance Industries and UPL. Among sectors, buying was SECTORIAL INDICES seen in the auto stocks, while IT, metal and energy stocks CLOSE CHANGE (%) remained under pressure. GLOBAL FACE CNX 100 11931.35 S&P CNX 500 ! Asian Market - Asian markets finished broadly higher today with shares in Hong Kong leading the region. The Hang Seng is up 1.42% while Japan's Nikkei 225 is up 1.19% and China's CNX 200 BANK NIFTY 31269.50 Shanghai Composite is up 0.69%. TOP GAINERS ! U.S. Market – North and South American markets finished mixed as of the most recent closing prices. The Bovespa CLOSE CHANGE (%) gained 0.60%, while U.S.'s S&P 500 was off 0.12%. Shares in Mexico were unchanged with the IPC at 43,792.08. ! European markets – European markets are lower today with shares in London off the most. The FTSE 100 is down 0.44% while France's CAC 40 is off 0.35% and Germany's DAX is lower by 0.04%. TOP LOSERS CLOSE CHANGE (%) TECHM UPL RELIANCE Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NIFTY SPOT MARKET MOVERS UPSIDE TREND STRATEGY SCRIPT CLOSE (%) S3 S2 11767 R1 R3 12038 INFRATEL 11677 11804 11857 11894 11948 RESISTANCE R1-11990 R2-12130 SUPPORT S1-11710 S2-11600 CLOSE (%) -2.10 -1.23 ITC WIPRO -1.21 -1.03 NET BUY (CR.) NET SELL (CR) STRATEGY SELL ON RISE 4267.33 PIVOT POINTS P 31296 SUPPORT S1-31000 S2-30820 DII 3267.69 S1 R1 R2 R3 31977 30614 30955 31112 31453 31637 RESISTANCE R1-31500 NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY 6 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS Adani Ports raises $750mn via! overseas bonds ! Sun Pharma enters into a license agreement with China Medical System Holdings Z o n e Adani Wednesday launched a repay existing loans and finance capital expenditure, as per media reports. The funds are planned to be used for capital expenditure, including on-lending to subsidiaries to meet their capital expenditure needs, existing debt. The fixed rate unsecured notes listed on the Singapore Exchange. denominated bonds are priced at a mark-up of 265 basis points over the 10-year US benchmark yield," according to a LiveMint report. L&T Hydrocarbon Engineering bags twin contracts from ONGC L&T- Hydrocarbon Engineering Limited (LTHE), a wholly owned subsidiary of Larsen orders from Oil & Natural Gas Corporation (ONGC). The Engineering, Procurement, Construction, Installation and contractsawarde Ports Special Economic Ltd. on Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has entered into a licensing agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for the development and commercialization of Tildrakizumab, an innovative biologic product, for psoriasis and psoriatic arthritis in Greater China (including Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region and Taiwan). Under terms of the license agreement, CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone $750mn offshore bond sale to and for repaying shall be The US dollar- ! payments, and royalties on net sales, the terms of which are confidential. CMS will be responsible for development, regulatory filings and commercialization of the product in China. The initial tenure of the agreement shall be 15 years from the first commercial sale of Tildrakizumab in Greater China, and may be & Toubro, has won twin d are for extended for additional 3 years subject to certain conditions defined in the agreement. Development of Heera Panna Block of Western Offshore basin which is located about 70 km of South West of Mumbai High. The project includes two (02 Nos.) wellhead platforms, -49km subsea rigid pipelines, 10 nos. of riser installation and modification work at seven existing platforms and Heera Process Complex, the company said in the press note. ! Trump demands India withdraw tariffs ahead of meeting with Modi Ahead of meeting with Indias PM Modi on the G20 Summit, US President Donald Trump has hit out at the Modi government and said that India's tariffs on US products is "unacceptable" and they must be withdrawn, according to the media reports. .

5. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : DHANUKA DATE : 28/06/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY DHANUKA IN CASH ABOVE 437 TGT 450 SL 425 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Sharemarket company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

9. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.